Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited company information, Employees & Contact Information

Explore related pages

Telix Pharmaceuticals Limited email format Telix Pharmaceuticals Limited management contacts

Related company profiles:

Telix is a biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic ('theranostic') radiopharmaceuticals. Telix is headquartered in Melbourne, Australia with commercial operations in the United States, Europe (Belgium and Switzerland) and Japan. Telix is developing a portfolio of radiopharmaceutical products that aims to address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX).

Company Details

Employees
601
Founded
-
Address
55 Flemington Rd, North Melbourne,victoria 3051,australia
Email
in****@****rma.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
telixpharma.com
Keywords
Oncology, Theranostics, Radiology, Radiopharmaceuticals, Cancer, Prostate Cancer, Renal Cancer, Glioblastoma, Positron Emission Tomography, Nuclear Medicine, Molecularly Targeted Radiation, Urology, Molecular Imaging, Cancer Imaging, Cancer Therapy.
HQ
North Melbourne, Victoria
Competitors
Clarity Pharmaceuticals, AstraZeneca, Lantheus, Eli Lilly and Company, Curium Pharma, Novartis, AbbVie, Fusion Pharmaceuticals, Sanofi, RLS Radiopharmacies.
Looking for a particular Telix Pharmaceuticals Limited employee's phone or email?

Telix Pharmaceuticals Limited Questions

News

TLX250-CDx (Zircaix®) Included in Leading International Guidelines for Renal Imaging - Laotian Times

TLX250-CDx (Zircaix®) Included in Leading International Guidelines for Renal Imaging Laotian Times

Telix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference - Yahoo Finance

Telix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference Yahoo Finance

Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis - GlobeNewswire

Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis GlobeNewswire

Development of a Novel Engineered Antibody Format for PSMA-Targeted Radionuclide Therapy - ACS Publications

Development of a Novel Engineered Antibody Format for PSMA-Targeted Radionuclide Therapy ACS Publications

Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain - Laotian Times

Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain Laotian Times

Global Healthcare Conferences: Telix CEO to Present at Morgan Stanley and H.C. Wainwright Events in NYC - Stock Titan

Global Healthcare Conferences: Telix CEO to Present at Morgan Stanley and H.C. Wainwright Events in NYC Stock Titan

Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S. - Yahoo Finance

Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S. Yahoo Finance

Telix Precision Medicine Announces AlFluor Radiochemistry Platform - Yahoo Finance

Telix Precision Medicine Announces AlFluor Radiochemistry Platform Yahoo Finance

Telix Investor Day in New York City on June 11, 2025: Presenting KOLs - GlobeNewswire

Telix Investor Day in New York City on June 11, 2025: Presenting KOLs GlobeNewswire

Anne Whitaker Appointed as Non-Executive Director - GlobeNewswire

Anne Whitaker Appointed as Non-Executive Director GlobeNewswire

FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review - GlobeNewswire

FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review GlobeNewswire

Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals - GlobeNewswire

Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals GlobeNewswire

Telix Announces Cardinal Health for Gozellix Commercial Distribution - Yahoo Finance

Telix Announces Cardinal Health for Gozellix Commercial Distribution Yahoo Finance

CMS Grants Transitional Pass-Through Status for Gozellix - GlobeNewswire

CMS Grants Transitional Pass-Through Status for Gozellix GlobeNewswire

CMS issues reimbursement code for PSMA-PET imaging agent Gozellix - Urology Times

CMS issues reimbursement code for PSMA-PET imaging agent Gozellix Urology Times

ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix® - Yahoo Finance

ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix® Yahoo Finance

Telix Announces H1 2025 Earnings Date: Global Investors Briefing Set for August 21 - Stock Titan

Telix Announces H1 2025 Earnings Date: Global Investors Briefing Set for August 21 Stock Titan

Approval sought for TLX007-CDx in prostate cancer - Urology Times

Approval sought for TLX007-CDx in prostate cancer Urology Times

Medicare Grants Crucial Reimbursement Code for Telix's Next-Gen Prostate Cancer Imaging Agent - Stock Titan

Medicare Grants Crucial Reimbursement Code for Telix's Next-Gen Prostate Cancer Imaging Agent Stock Titan

Telix Announces Launch of Proposed Initial Public Offering in the United States - GlobeNewswire

Telix Announces Launch of Proposed Initial Public Offering in the United States GlobeNewswire

Telix ADSs Commence Trading on Nasdaq - GlobeNewswire

Telix ADSs Commence Trading on Nasdaq GlobeNewswire

Telix to Expand Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical - PR Newswire

Telix to Expand Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical PR Newswire

First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib - PR Newswire

First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib PR Newswire

Telix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals - aap.com.au

Telix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals aap.com.au

Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia - Yahoo Finance

Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia Yahoo Finance

Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide - aap.com.au

Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide aap.com.au

Companies like Telix Pharmaceuticals Limited

Novartis logo - Similar company to Telix Pharmaceuticals Limited

Novartis

79.78K
Eli Lilly and Company logo - Similar company to Telix Pharmaceuticals Limited

Eli Lilly And Company

51.50K
AbbVie logo - Similar company to Telix Pharmaceuticals Limited

Abbvie

57.01K
Lantheus logo - Similar company to Telix Pharmaceuticals Limited

Lantheus

1.22K
Clarity Pharmaceuticals logo - Similar company to Telix Pharmaceuticals Limited

Clarity Pharmaceuticals

65
Sanofi logo - Similar company to Telix Pharmaceuticals Limited

Sanofi

88.33K
Curium Pharma logo - Similar company to Telix Pharmaceuticals Limited

Curium Pharma

1.83K
AstraZeneca logo - Similar company to Telix Pharmaceuticals Limited

Astrazeneca

78.61K
Fusion Pharmaceuticals logo - Similar company to Telix Pharmaceuticals Limited

Fusion Pharmaceuticals

149
RLS Radiopharmacies logo - Similar company to Telix Pharmaceuticals Limited

Rls Radiopharmacies

389

Top Telix Pharmaceuticals Limited Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant